Position in LLY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$13,392,836
+$1,726,474 QoQ
Shares Held
11,166
-12.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
6.43%
of 13F equity value
Holder Rank
#1,095
of 4,605 holders
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fairfield Financial Advisors, LTD holds $15,764,978 across 4 Drug Manufacturers - General names. LLY ranks #1 (85.0% of the industry book) .
All Filings in LLY
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,392,836 | 11,166 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $11,666,362 | 12,684 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $13,624,794 | 12,678 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $9,952,572 | 13,044 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $11,066,207 | 14,196 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $12,016,164 | 14,549 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $11,323,696 | 14,668 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $12,969,275 | 14,639 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $12,865,449 | 14,210 | Shares | Sole | 2024-08-09 | |
| 2023-12-31 | $8,268,137 | 14,184 | Shares | Sole | 2024-11-04 | |
| 2023-09-30 | $7,300,670 | 13,592 | Shares | Sole | 2024-11-04 | |
| 2023-06-30 | $6,036,241 | 12,871 | Shares | Sole | 2024-11-04 | |
| 2023-03-31 | $3,970,278 | 11,561 | Shares | Sole | 2024-11-04 | |
| 2022-12-31 | $3,745,835 | 10,239 | Shares | Sole | 2024-10-07 | |
| 2022-09-30 | $3,238,350 | 10,015 | Shares | Sole | 2024-10-07 | |
| 2022-06-30 | $2,972,864 | 9,169 | Shares | Sole | 2024-10-07 | |
| 2022-03-31 | $2,591,648 | 9,050 | Shares | Sole | 2024-10-07 | |
| No filing history on record for this holder in this stock. | ||||||